Department of Pathology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Department of Dermatology, Central Theater General Hospital of Chinese People's Liberation Army, Wuhan, China.
Int J Dermatol. 2021 Apr;60(4):497-502. doi: 10.1111/ijd.15372. Epub 2020 Dec 28.
Primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoproliferative disorder has been defined as a type of lymphoproliferative disorder with indolent clinical course and excellent prognosis, yet a precise diagnosis is still hard to reach.
A retrospective analysis of 22 patients including 16 females and six males was performed.
The age of patients ranged from 5 to 79 years. The average age of all patients was 43.5, and the median age of all patients was 44.5. Two patients had multiple lesions, and others were presented with a solitary asymptomatic lesion. Besides general features, folliculotropism was observed in four cases. In addition to express CD3 and CD4, CD30 were positive to some extent. Some reactive cells could express CD8 and CD20. For follicular helper T-cell markers, although CXCL-13 was negative in the stained cases (18/18), the expression of PD-1 (12/17), BCL-6 (12/16) and CD10 (11/15) was observed in most cases. In addition, we performed T-cell receptor (TCR) rearrangement on five patients, and all of them showed monoclonality. Nearly all patients had excellent prognosis.
Primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoproliferative disorder is complex. Some features like folliculotropism should also be noted. Besides, the expression of follicular helper T-cell markers is not invariable. Moreover, CD8 positivity, Ki-67 index, and lesion number were perhaps not absolute prognostic indicators. To reach a diagnosis of this rare entity, putting all the pieces together is important.
原发性皮肤 CD4 阳性小/中体型多形性 T 细胞淋巴增生性疾病已被定义为一种临床过程惰性和预后良好的淋巴增生性疾病,但准确诊断仍难以实现。
对 22 例患者(16 例女性和 6 例男性)进行回顾性分析。
患者年龄 5~79 岁,平均年龄 43.5 岁,中位年龄 44.5 岁。2 例患者有多个皮损,其余患者表现为单发无症状皮损。除一般特征外,4 例存在滤泡亲嗜性。除表达 CD3 和 CD4 外,CD30 也不同程度阳性,部分反应性细胞可表达 CD8 和 CD20。对于滤泡辅助 T 细胞标志物,虽然染色病例中 CXCL-13 均为阴性(18/18),但 PD-1(12/17)、BCL-6(12/16)和 CD10(11/15)的表达在大多数病例中均可见。此外,我们对 5 例患者进行了 T 细胞受体(TCR)重排,均显示单克隆性。几乎所有患者均预后良好。
原发性皮肤 CD4 阳性小/中体型多形性 T 细胞淋巴增生性疾病较为复杂,一些特征如滤泡亲嗜性也应注意。此外,滤泡辅助 T 细胞标志物的表达并非一成不变。此外,CD8 阳性、Ki-67 指数和皮损数量可能不是绝对的预后指标。要诊断这种罕见疾病,综合所有因素非常重要。